STAT3 and prostate carcinoma: Jin et al. further revealed that the STAT3 inhibitor methyllucidone, a natural compound derived from the fruits of Lindera erythrocarpa Makino, inhibited STAT3 activation by upregulating MEG2 expression and, thereby, was effective at inhibiting prostate cancer cell survival and proliferation [114].